Home > Healthcare & Medical Devices > Sleep Apnea Devices Market

Sleep Apnea Devices Market Size By Product (Therapeutics {Airway Clearance System, Adaptive Servo-ventilation {ASV}, Positive Airway Pressure {PAP} Device, Oral Appliances, Oxygen Devices}, Diagnostics {Actigraphy Systems, Polysomnography {PSG} Device, Respiratory Polygraph, Sleep Screening Devices}), By End-use (Home Care Settings & Individuals, Sleep Laboratories & Hospitals), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2030

  • Report ID: GMI489
  • Published Date: Oct 2022
  • Report Format: PDF

Industry Drivers

Sleep Apnea Devices Market size was estimated to be worth more than USD 6.5 billion in 2021 and is poised to grow at over 8% CAGR from 2022 to 2030 owing to the growing prevalence of sleep apnea worldwide.
 

Get more details on this report - Request Free Sample PDF
 

One of the major factors driving the industry progression is the upsurge in the number of individuals suffering from sleep apnea and related co-morbidities. The industry is also speculated to witness substantial gain due to rising product demand among the enlarging patient population for the dependability and ergonomic design of these devices that allow easy sleep testing. 
 

Lack of adherence to sleep apnea therapy may restrain Sleep Apnea Devices Market expansion

Continuous positive airway pressure (CPAP) is widely regarded as one of the most effective treatments for obstructive sleep apnea syndrome (OSAS). In order to control the condition, CPAP must be used correctly and consistently. Many individuals feel discomfort when using a CPAP device and stop using it. However, the latest generation of masks and the addition of new comfort features to the CPAP devices would assist in customizing the device as per patient requirements without interrupting their sleep, which is expected to help the industry overcome this limitation.
 

Proliferating awareness of benefits to propel diagnostics business share

Get more details on this report - Request Free Sample PDF
 

In terms of product, the sleep apnea devices market is bifurcated into diagnostics and therapeutics. The diagnostics segment held a significant market share in 2021 and is forecast to exceed USD 4.5 billion by 2030. The rising demand and increased knowledge pertaining to the various benefits provided by sleep apnea testing devices in the diagnosis of multiple sleep ailments, such as precise disease diagnosis, treatment efficacy evaluation, and so on, are likely to bolster segment development.
 

Soaring patient preference to supplement sleep laboratories & hospitals segment progress

Get more details on this report - Request Free Sample PDF
 

As per end-use, the sleep apnea devices market is segregated into home care settings & individuals and sleep laboratories & hospitals. The sleep laboratories & hospitals segment is expected to grow steadily at over 7% CAGR through 2030 mainly backed by the growing inclination of patients toward sleep laboratories and hospitals for quality sleep disorders treatment and affordability. Recent studies indicate that investigations done on patients in sleep laboratories and hospitals provide an accurate diagnosis that enables precise and effective therapy, resulting in excellent treatment outcomes.
 

Booming prominence of early diagnosis to favor North America industry expansion

Get more details on this report - Request Free Sample PDF
 

North America contributed sleep apnea devices market surpassed USD 2.5 billion in 2021. This is driven by various factors, including the existence of prominent manufacturers and surging awareness of early diagnosis, among others. Furthermore, mounting incidences of sleep apnea and other sleep disorders in the region are slated to push market progress. According to Sleep Foundation research published in 2022, around 34% of men and 17% of women in the United States suffer from OSA.
 

Effective expansion strategies to define the competitive spectrum

The sleep apnea devices market includes Fisher & Paykel Healthcare, Natus Medical Inc., Invacare Corporation, ResMed Inc., Koninklijke Philips N.V., and Teleflex Inc., among other companies. Industry players are working on product launches and expanding their product offerings to gain a competitive edge in the business.
 

Impact of COVID-19 on the sleep apnea devices market trends

The COVID-19 outbreak raised unprecedented health concerns and had a detrimental influence on the sleep apnea equipment industry in early 2020. However, technical advancements in sleep apnea devices and the widespread use of telemedicine have increased product penetration. Moreover, favorable efforts taken to boost consumer awareness about the disorder and its treatment during the COVID-19 pandemic have also contributed to the high product demand.
 

The sleep apnea devices market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2030 for the following segments:

By Product

  • Therapeutics
    • Airway Clearance Systems
    • Adaptive Servo-ventilation (ASV)
    • Positive Airway Pressure (PAP) Device
    • Oral Appliances
    • Oxygen Devices
    • Others
  • Diagnostics
    • Actigraphy Systems
    • Polysomnography (PSG) Device
    • Respiratory Polygraph
    • Sleep Screening Devices

By End-use

  • Home Care Settings & Individuals
  • Sleep Laboratories & Hospitals

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina 
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

 

Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

The sleep apnea devices industry was worth over USD 6.5 billion in 2021 and is set to expand at an 8% CAGR through 2030 due to the increasing prevalence of sleep apnea worldwide.
The diagnostics segment held a significant market share in 2021 and is estimated to generate more than USD 4.5 billion in revenue by 2030 owing to the benefits of these devices in diagnosing several sleep-related ailments.
Leading companies in the sleep apnea devices market include Koninklijke Philips N.V., Fisher & Paykel Healthcare, Invacare Corporation, ResMed Inc., Natus Medical Inc., and Teleflex Inc., among others.
The sleep labs & hospitals segment is projected to expand at more than 7% CAGR through 2030 owing to rising patient preference for these settings due to the availability of affordable and quality sleep disorders treatment options.

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 14
  • Tables & Figures: 245
  • Countries covered: 18
  • Pages: 177
  • Upcoming Report: Details can be customized to meet your information and data needs. Feel free to share your detailed research requirements via this form.

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount